tiprankstipranks
Interpace Diagnostics Group (IDXG)
OTHER OTC:IDXG

Interpace Diagnostics Group (IDXG) Income Statement

409 Followers

Interpace Diagnostics Group Income Statement

Last quarter (Q3 2023), Interpace Diagnostics Group's total revenue was $9.08M, an increase of 10.86% from the same quarter last year. In Q3, Interpace Diagnostics Group's net income was $-614.00K. See Interpace Diagnostics Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 33.85M$ 31.84M$ 33.12M$ 32.40M$ 24.22M$ 21.90M
Cost of Revenue
$ 5.55M$ 13.61M$ 14.31M$ 21.67M$ 15.89M$ 10.20M
Gross Profit
$ 22.77M$ 18.23M$ 18.80M$ 10.72M$ 8.33M$ 11.70M
Operating Expense
$ 3.59M$ 21.85M$ 24.70M$ 34.70M$ 32.28M$ 22.81M
Operating Income
$ 26.84M$ -3.62M$ -5.90M$ -23.98M$ -23.95M$ -11.11M
Net Non Operating Interest Income Expense
$ 121.00K$ -158.00K$ -920.00K$ -549.00K$ -440.00K$ -331.00K
Other Income Expense
$ 1.36M$ 988.00K$ 925.00K$ -1.62M$ -2.29M$ -1.26M
Pretax Income
$ 1.78M$ -5.84M$ -7.74M$ -26.15M$ -26.68M$ -12.70M
Tax Provision
$ 10.00K$ 29.00K$ -705.00K$ 53.00K$ -28.00K$ 18.00K
Earnings From Equity Interest Net Of Tax
$ 700.00K-----
Net Income Common Stockholders
$ 16.66M$ -21.11M$ -14.94M$ -29.48M$ -27.17M$ -12.70M
Basic EPS
$ -0.49$ -10.36$ -7.22$ -7.32$ -7.25$ -4.52
Diluted EPS
$ -0.12$ -10.36$ -7.22$ -7.32$ -7.25$ -4.52
Basic Average Shares
$ 17.18M$ 4.24M$ 4.13M$ 4.03M$ 3.75M$ 2.82M
Diluted Average Shares
$ 17.18M$ 4.24M$ 4.13M$ 4.03M$ 3.75M$ 2.82M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 9.14M$ 35.45M$ 39.01M$ 56.38M$ 48.17M$ 33.01M
Net Income From Continuing And Discontinued Operation
$ -1.57M$ -21.96M$ -14.94M$ -26.45M$ -26.74M$ -12.70M
Normalized Income
$ -413.96K$ 8.77M-$ -24.68M$ -24.16M$ -11.61M
Interest Expense
---$ 549.00K$ 440.00K$ 331.00K
EBIT
$ 1.82M$ -6.65M$ -7.25M$ -25.60M$ -26.24M$ -12.37M
EBITDA
$ 2.70M$ -4.03M$ -1.75M$ -20.10M$ -21.72M$ -8.57M
Currency in USD

Interpace Diagnostics Group Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis